EAU 2023 | Best of EAU23: renal cancer

Carmen Mir Maresma, MD, PhD, FEBU, Fundacion Instituto Valenciano Oncologia, Valencia, Spain, shares the best of EAU 2023 abstracts in renal cancer, including results from a prospective observational study deciphering the relationship between pathogenic variants and clinical phenotype in VHL patients, long-term prognosis and risk stratification for adult mit family translocation renal cell carcinoma (RCC), and finally the prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear RCC. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.